These data confirmed that the combination of OxP and PD-L1 trap revoked the immunosuppressive tumor microenvironment of orthotopic CT26-FL3 tumor, resulting in the activation of T cells and consequently increased efficacy of the immune therapy. The gene discussed is CD274; the disease is neoplasm.